Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by zakmirzaon Jan 20, 2016 10:34am
180 Views
Post# 24476303

Some Facts

Some Facts Historically FDA has approved a product 85% of the time when the Adcomm has been a yes. The FDA has rejected approval 86% of the time when the Adcomm is negative. Hmm! I feel approval is a toss up however. If Valstar with 10% success can get approved, MCNA with 25% success and significantly better safety and tolerability should be approved. Something, Adcomms this large are not common.
<< Previous
Bullboard Posts
Next >>